You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DMRA Buy Disclosure
Jarrett Jennifer · SEC Form 4 · Filed Sep 28, 2026
Buy
Calculated transaction value
$252.88K
Jarrett Jennifer Director, President And CEO
DMRA
Transaction date
Sep 25, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed 3 days later
DMRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 12,500 shares @ $20.23
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-403355
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$252.88K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Damora Therapeutics, Inc. DMRA Current | Buy | Sep 25, 2026 | $252.88K |